tradingkey.logo
tradingkey.logo
検索

Anika Therapeutics Inc

ANIK
ウォッチリストに追加
14.620USD
-0.110-0.75%
終値 06/25, 16:00ET15分遅れの株価
194.53M時価総額
損失額直近12ヶ月PER

詳細情報 Anika Therapeutics Inc 企業名

Anika Therapeutics, Inc. is engaged in the osteoarthritis pain management and regenerative solutions space focused on early intervention orthopedics. The Company is leveraging its core expertise in hyaluronic acid and implant solutions. It partners with clinicians to provide minimally invasive products that restore active living for people around the world. It is developing, manufacturing and commercializing products on its hyaluronic acid (HA) technology platform. It is focused on spaces within orthopedics, including osteoarthritis pain management and regenerative solutions, and its products are delivered in key sites of care, including ambulatory surgery centers. Its products include OA Pain Management, Regenerative Solutions, and others. The OA Pain Management product family consists of Cingal, Monovisc, Orthovisc, Orthovisc mini and Orthovisc-T. Its Regenerative Solutions include Integrity, Hyalofast, Tactoset and NanoFx.

Anika Therapeutics Incの企業情報

企業コードANIK
会社名Anika Therapeutics Inc
上場日May 16, 1985
最高経営責任者「CEO」Blanchard (Cheryl Renee)
従業員数288
証券種類Ordinary Share
決算期末May 16
本社所在地32 Wiggins Ave
都市BEDFORD
証券取引所NASDAQ OMX - NASDAQ BASIC
United States of America
郵便番号01730-2315
電話番号17814579000
ウェブサイトhttps://anika.com/
企業コードANIK
上場日May 16, 1985
最高経営責任者「CEO」Blanchard (Cheryl Renee)

Anika Therapeutics Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Stephen D. (Steve) Griffin
Mr. Stephen D. (Steve) Griffin
Chief Financial Officer, Chief Operating Officer, Executive Vice President
Chief Financial Officer, Chief Operating Officer, Executive Vice President
90.25K
+10.05%
Dr. Glenn R. Larsen, Ph.D.
Dr. Glenn R. Larsen, Ph.D.
Independent Director
Independent Director
50.26K
--
Ms. Sheryl L. Conley
Ms. Sheryl L. Conley
Independent Director
Independent Director
42.57K
+6.40%
Mr. William R. (Bill) Jellison
Mr. William R. (Bill) Jellison
Independent Director
Independent Director
23.10K
--
Mr. Joseph H. (Joe) Capper
Mr. Joseph H. (Joe) Capper
Independent Director
Independent Director
20.40K
--
Dr. Cheryl Renee Blanchard, Ph.D.
Dr. Cheryl Renee Blanchard, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Susan L. N. Vogt
Ms. Susan L. N. Vogt
Independent Director
Independent Director
--
--
Mr. David B. Colleran, J.D.
Mr. David B. Colleran, J.D.
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
--
--
Mr. John Bell (Jack) Henneman, III
Mr. John Bell (Jack) Henneman, III
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Stephen O. Richard
Mr. Stephen O. Richard
Independent Director
Independent Director
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Stephen D. (Steve) Griffin
Mr. Stephen D. (Steve) Griffin
Chief Financial Officer, Chief Operating Officer, Executive Vice President
Chief Financial Officer, Chief Operating Officer, Executive Vice President
90.25K
+10.05%
Dr. Glenn R. Larsen, Ph.D.
Dr. Glenn R. Larsen, Ph.D.
Independent Director
Independent Director
50.26K
--
Ms. Sheryl L. Conley
Ms. Sheryl L. Conley
Independent Director
Independent Director
42.57K
+6.40%
Mr. William R. (Bill) Jellison
Mr. William R. (Bill) Jellison
Independent Director
Independent Director
23.10K
--
Mr. Joseph H. (Joe) Capper
Mr. Joseph H. (Joe) Capper
Independent Director
Independent Director
20.40K
--
Dr. Cheryl Renee Blanchard, Ph.D.
Dr. Cheryl Renee Blanchard, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--

よくある質問

Anika Therapeutics Incの上位5名の株主は誰ですか?

Anika Therapeutics Incの上位5名の株主は以下のとおりです。Mr. Stephen D. (Steve) Griffin

Anika Therapeutics Inc(ANIK)の株式を保有している機関の数はいくつですか?

2026Q1時点で、Anika Therapeutics Incの株式を保有している機関は264社あり、保有株式の総市場価値は約12.85Mで、全体の96.55%を占めています。2025Q4と比較して、機関の持ち株は-1611291.00増加しています。

Anika Therapeutics Incの最大の収益源は何ですか?

2026Q1において、OEM Channel部門がAnika Therapeutics Incにとって最大の収益を生み出しており、その金額は64.41Mで、全収益の57.09%を占めています。
KeyAI